Current Challenges in Management of Neurological Disorders (Part-I)

  • Kamal M
  • Abdel-Daim M
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

There are various health issues worldwide such as osteoporosis, cancer, obesity, infectious diseases, neurological disorders (Alzheimer's disease, Parkinson's disease) and neuropsychiatric disorders. There are many topics to discuss about each disease such as pathology, causes, symptoms, risk factors, diagnosis, current management as well as new research to discover best treatment strategies. There are many advanced researches to manage health issues via nanotechnological, nanomedicines, stem cells and vaccines. The vaccines stimulate the production of long-lived memory cells/plasma cells to produce antibodies to defend the body against viral or bacterial (antigens) attacks. The aim of this special issue of Current Pharmaceutical Design was to aid pharmaceutical research in this exertion by providing articles for an overview of current progress and future perspectives focused towards management strategies for neurological disorders. Particular challenges facing numerous laboratories are those that involve laboratory bench to clinical bedside in the path of successful drug discovery. Authors of this special issue (Part-I) were requested to provide a review (Table 1), sufficient for an inspiration to identify guidelines for in vitro to clinically translatable research that will enhance the rate treatment can reach its public health goals globally.

Cite

CITATION STYLE

APA

Kamal, M. A., & Abdel-Daim, M. M. (2020). Current Challenges in Management of Neurological Disorders (Part-I). Current Pharmaceutical Design, 26(7), 711–713. https://doi.org/10.2174/138161282607200309122739

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free